Related Experiment Videos
DNA synthesis during hormone-dependent mammary tumor regression in rats
Abstract:
A serial biopsy method was developed to study DNA synthesis in 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors during the regression process induced by bromocryptine (CB-154) administration in highly inbred female SD rats. With this technique the changes in tumor size could be correlated with those of DNA synthesis in single regressing tumors. DNA synthesis was estimated by the in vitro incorporation of tritiated thymidine into DNA which correlated well (correlation coefficient r = 0.95) with the in vivo mitotic activity of these neoplasms. Neither the biopsies themselves nor the estral status of the hosts affected significantly the rate of tumor DNA synthesis. DNA synthesis decreased sharply 4-8 days after the beginning of CB-154 treatment, whereas tumor shrinkage occurred more gradually. In conclusion, the serial biopsy method is a reliable technique for the estimation of changes in DNA synthesis in regressing DMBA-induced rat mammary tumors, whereas the measurement of the rate of tumor shrinkage is not.
Insights
Serial biopsies reliably track DNA synthesis in rat mammary tumors during bromocryptine treatment. Tumor shrinkage is a less accurate measure of regression compared to DNA synthesis changes.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- 7,12-dimethylbenz[a]anthracene (DMBA) induces mammary tumors in rats, providing a model for cancer research.
- Bromocryptine (CB-154) is used to induce tumor regression, offering insights into treatment efficacy.
- Understanding DNA synthesis dynamics is crucial for evaluating anti-cancer drug effects.
Purpose of the Study:
- To develop and validate a serial biopsy method for assessing DNA synthesis in regressing rat mammary tumors.
- To correlate changes in DNA synthesis with tumor size reduction during bromocryptine treatment.
- To evaluate the reliability of DNA synthesis measurement versus tumor shrinkage for monitoring regression.
Main Methods:
- A serial biopsy technique was employed in highly inbred female SD rats with DMBA-induced mammary tumors.
- DNA synthesis was quantified by in vitro tritiated thymidine incorporation into tumor DNA.
- In vivo mitotic activity and tumor size changes were also monitored.
Main Results:
- The serial biopsy method demonstrated a strong correlation (r = 0.95) between in vitro DNA synthesis and in vivo mitotic activity.
- Tumor DNA synthesis decreased sharply 4-8 days post-bromocryptine administration.
- Tumor size reduction occurred more gradually than the decrease in DNA synthesis.
Conclusions:
- Serial biopsy is a reliable method for estimating DNA synthesis changes in regressing DMBA-induced rat mammary tumors.
- Measuring tumor shrinkage is a less precise indicator of regression compared to DNA synthesis rates.
- This technique allows for accurate correlation of DNA synthesis with tumor regression dynamics.